ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Half Of Women Complete Full Hormone Therapy Regimen

July 30, 2010

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014